Daily technical summary · updated 2026-10-01
As of 2026-10-01, Novo Nordisk (NVO) shows an overall Sell technical signal with 65% confidence, based on ~20 indicators computed on daily prices. Its 14-day RSI is 27 (oversold). The MACD line is below its signal line (bearish momentum). The stock is in a downtrend (below its 200-day average). Active alert(s): RSI oversold (below 30); Below 61.8% Fibonacci retracement.
Loading interactive chart…
👆 Tip: click any indicator row in the tables below to plot it on the chart.
| Indicator | Period | Value | Signal |
|---|---|---|---|
| RSI | 14d | 27.3 | Buy |
| Stochastic | 14,3,3 | 2.16 | Neutral |
| StochRSI | 14,3,3 | 7.61 | Buy |
| CCI | 20d | -86.57 | Neutral |
| WilliamsR | 14d | -99.53 | Buy |
| MACD | 12,26,9 | -2.1369 | Sell |
| Momentum | 10d | -5.79 | Sell |
| AwesomeOsc | 5/34 | -5.2998 | Neutral |
| UltimateOsc | 7/14/28 | 35.51 | Neutral |
| ADX | 14d | 31.9 | Sell |
| Indicator | Period | Value | Signal |
|---|---|---|---|
| SMA10 | 10d | 39.036 | Sell |
| EMA10 | 10d | 39.1639 | Sell |
| SMA20 | 20d | 41.6075 | Sell |
| EMA20 | 20d | 40.9266 | Sell |
| SMA30 | 30d | 43.2297 | Sell |
| EMA30 | 30d | 42.1178 | Sell |
| SMA50 | 50d | 44.6922 | Sell |
| EMA50 | 50d | 43.3855 | Sell |
| SMA100 | 100d | 45.1893 | Sell |
| EMA100 | 100d | 44.2882 | Sell |
| SMA200 | 200d | 44.6327 | Sell |
| EMA200 | 200d | 46.4141 | Sell |
| VWMA20 | 20d | 40.6942 | Sell |
| Indicator | Period | Value | Signal |
|---|---|---|---|
| OBV | cum | -550649400.0 | Sell |
| MFI | 14d | 18.48 | Buy |
| Indicator | Period | Value | Signal |
|---|---|---|---|
| Bollinger%B | 20d,2σ | 0.164 | Neutral |
The overall Sell reading blends around twenty technical indicators — momentum oscillators (RSI, MACD, Stochastic), trend (moving averages, ADX), volume (OBV, MFI) and volatility (Bollinger Bands) — each voting buy, hold or sell on Novo Nordisk's daily price. RSI below 30 is oversold and above 70 overbought; a MACD line crossing above its signal line is a bullish momentum signal; price above a rising 200-day average indicates an uptrend.
No recent headlines found for Novo Nordisk right now.
As of 2026-10-01, Novo Nordisk has an overall Sell technical signal at 65% confidence, aggregated from about 20 daily indicators. This is automated technical information for education, not financial advice.
Novo Nordisk's 14-day RSI is 27, which is oversold (below 30).
Novo Nordisk's MACD line is below its signal line — a bearish momentum reading.
Novo Nordisk is currently showing a downtrend based on where its price sits relative to its 200-day moving average.
Apple · Tesla · Nvidia · Amazon · Microsoft · Alphabet (Google) · Meta Platforms · AMD · S&P 500 ETF (SPY) · Nasdaq 100 ETF (QQQ) · Palantir · Rolls-Royce · Browse all 175 stocks & ETFs →
⚠️ Not financial advice. DailyTechnicals provides automated technical information for educational purposes only. Technical indicators describe probabilities, not certainties, and have not been shown to reliably beat a buy-and-hold strategy. Do your own research and consider professional advice before investing. Data may be delayed. © 2026 DailyTechnicals.